Total Payments
$5,835
2024 Payments
$771.38
Companies
41
Transactions
395
Medicare Patients
34,508
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$5,815 (99.7%)
Education$19.89 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,815 | 393 | 99.7% |
| Education | $19.89 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,194 | 94 | $0 (2024) |
| ABBVIE INC. | $722.43 | 49 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $713.72 | 43 | $0 (2024) |
| PFIZER INC. | $453.31 | 31 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $302.66 | 20 | $0 (2023) |
| Amgen Inc. | $298.10 | 22 | $0 (2024) |
| Lilly USA, LLC | $278.34 | 20 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $236.87 | 15 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $227.82 | 15 | $0 (2024) |
| Allergan, Inc. | $180.14 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $771.38 | 51 | Novo Nordisk Inc ($171.27) |
| 2023 | $828.12 | 56 | PFIZER INC. ($228.89) |
| 2022 | $906.49 | 60 | ABBVIE INC. ($188.33) |
| 2021 | $761.44 | 58 | AbbVie Inc. ($203.89) |
| 2020 | $453.54 | 28 | Novo Nordisk Inc ($90.90) |
| 2019 | $565.12 | 38 | Novo Nordisk Inc ($172.96) |
| 2018 | $694.55 | 50 | Novo Nordisk Inc ($149.61) |
| 2017 | $854.05 | 54 | Boehringer Ingelheim Pharmaceuticals, Inc. ($193.14) |
All Payment Transactions
395 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Bone Health | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: DIABETES | ||||||
| 08/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Diabetes | ||||||
| 08/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: VACCINES | ||||||
| 08/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Gastroenterology | ||||||
| 07/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Obesity | ||||||
| 07/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Gastroenterology | ||||||
| 06/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 6,339 | 9,576 | $754,716 | $321,402 |
| 2022 | 57 | 7,983 | 11,841 | $872,295 | $370,272 |
| 2021 | 57 | 11,330 | 15,670 | $1.0M | $484,259 |
| 2020 | 55 | 8,856 | 13,517 | $876,294 | $382,395 |
Total Patients
34,508
Total Services
50,604
Medicare Billing
$1.6M
Procedure Codes
215
All Medicare Procedures & Services
215 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 494 | 1,233 | $295,920 | $98,139 | 33.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 423 | 423 | $103,212 | $53,269 | 51.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 207 | 346 | $58,820 | $19,478 | 33.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 249 | 249 | $29,631 | $17,839 | 60.2% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 112 | 112 | $26,096 | $16,016 | 61.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 45 | 52 | $24,492 | $10,774 | 44.0% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 404 | 404 | $20,604 | $10,197 | 49.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 503 | 1,240 | $11,855 | $9,992 | 84.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 264 | 265 | $10,335 | $7,990 | 77.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 485 | 1,037 | $17,629 | $7,870 | 44.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 389 | 584 | $16,936 | $7,662 | 45.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 425 | 683 | $15,709 | $7,048 | 44.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 387 | 387 | $13,545 | $7,001 | 51.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $10,626 | $6,214 | 58.5% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 112 | 112 | $8,176 | $4,502 | 55.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 33 | $10,494 | $4,213 | 40.1% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 15 | 15 | $6,526 | $3,619 | 55.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 22 | 22 | $7,411 | $3,556 | 48.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 195 | 320 | $6,720 | $3,046 | 45.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 137 | 161 | $5,957 | $2,650 | 44.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 52 | 52 | $6,396 | $1,947 | 30.4% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 36 | 37 | $2,701 | $1,487 | 55.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 29 | 31 | $4,480 | $1,413 | 31.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 40 | 40 | $1,560 | $1,206 | 77.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 117 | 145 | $2,610 | $1,195 | 45.8% |
About Dr. David Powers, MD
Dr. David Powers, MD is a Family Medicine healthcare provider based in South Hill, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215933494.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Powers, MD has received a total of $5,835 in payments from pharmaceutical and medical device companies, with $771.38 received in 2024. These payments were reported across 395 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,815).
As a Medicare-enrolled provider, Powers has provided services to 34,508 Medicare beneficiaries, totaling 50,604 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 215 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location South Hill, VA
- Active Since 06/22/2005
- Last Updated 01/13/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1215933494
Products in Payments
- Ozempic (Drug) $634.99
- JARDIANCE (Drug) $528.22
- UBRELVY (Drug) $331.05
- XIFAXAN (Drug) $227.82
- QULIPTA (Drug) $190.08
- ELIQUIS (Drug) $166.49
- Rybelsus (Drug) $164.53
- TOUJEO (Drug) $162.47
- Victoza (Drug) $152.22
- VRAYLAR (Drug) $147.58
- TRULICITY (Drug) $142.27
- NURTEC ODT (Drug) $138.60
- PREVNAR 20 (Biological) $113.42
- NATRELLE-INSPIRA (Device) $110.70
- ENTRESTO (Drug) $106.74
- Otezla (Drug) $103.17
- Vascepa (Drug) $95.62
- STIOLTO (Drug) $86.58
- STIOLTO RESPIMAT (Drug) $80.26
- SYMBICORT (Drug) $79.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in South Hill
Graham Powers, Md, MD
Family Medicine — Payments: $3,509
Family Medicine $3,509
Dr. Mark Carreras, M.d, M.D
Family Medicine — Payments: $436.58
Family Medicine $436.58
Dr. Bryan Mosora, D.o, D.O
Family Medicine — Payments: $336.41
Family Medicine $336.41
Mahmethan Shadid, Md, MD
Family Medicine — Payments: $265.79
Family Medicine $265.79
Jill Allen, Md, MD
Family Medicine — Payments: $63.83
Family Medicine $63.83
Graham Keats, Md, MD
Family Medicine
Family Medicine